Cardio Cases · pericardial-myocardial-other
Recurrent pericarditis and constrictive pericarditis — practice case: constriction after cardiac surgery
Practice case: a 58-year-old Australian man with right heart failure 10 weeks after bypass surgery; diagnosis of constriction with a near-normal natriuretic peptide and the Mayo Clinic echocardiographic criteria, CMR evidence of pericardial inflammation and anti-inflammatory therapy, then persistent constriction without inflammation, pericardiectomy with tricuspid repair, and outcomes.
On this page
Study tools
Target exams
- EECC
- ABIM Cardiovascular Disease Certification
Presentation
Practice case (not a real patient). A 58-year-old man in Sydney had coronary bypass surgery 10 weeks ago. Over 6 weeks he has developed ankle swelling, abdominal distension and breathlessness on exertion.[1] His jugular venous pressure is raised, he has ascites, and he is haemodynamically stable. NT-proBNP is near normal, C-reactive protein is raised, and left and right ventricular systolic function are preserved on echocardiography.[1]
Step 1 — Is this constriction?
Discussion:
- ESC 2025 describes the classic clinical picture of constriction as usually characterized by isolated right heart failure with normal or nearly normal natriuretic peptide levels; venous congestion, hepatomegaly, pleural effusions and ascites may occur.[1]
- Post-cardiac surgery accounts for 11%–37% of reported constriction in developed countries.[1]
- Multimodality imaging is recommended in all patients with suspected constrictive pericarditis to make the diagnosis and assess pericardial thickening, calcifications and active inflammation (Class I, Level C).[1]
- Echocardiography shows septal bounce, medial e' of 12 cm/s and a hepatic vein expiratory diastolic reversal ratio of 0.82, which meet the Mayo Clinic criteria quoted by ESC 2025 (septal bounce or septal shift with medial e' >8 cm/s or reversal ratio >0.78).[1]
- In a retrospective New South Wales cohort of all hospitalized patients with pericardial disease from 2004 to 2021, the median time from cardiac surgery to a diagnosis of constriction was 6 months.[22]
Step 2 — Is it inflamed?
CMR shows pericardial thickening with oedema and late gadolinium enhancement.[1]
- Pericardial LGE may imply ongoing inflammation and neovascularization rather than simple scarring.[1]
- Anti-inflammatory therapy is recommended in haemodynamically stable patients with a transient or new diagnosis of constriction and evidence of pericardial inflammation (C-reactive protein elevation or pericardial enhancement on CMR), to prevent progression to constriction and avoid pericardiectomy (Class I, Level C).[1]
- Transient constriction resolves with anti-inflammatory therapy in >50% of cases, and ESC 2025 Table 18 gives a 3–6 month course of empirical anti-inflammatory medical therapy.[1]
- Colchicine is recommended as first-line therapy in patients with pericarditis as an adjunct to aspirin/NSAID or corticosteroid therapy to reduce subsequent recurrences (Class I, Level A); the ESC 2025 Table 13 footnote says aspirin is the preferred choice for patients with ischaemic heart disease.[1]
Step 3 — Four months later
His symptoms have improved only partly. C-reactive protein is now normal and CMR shows no pericardial enhancement, but constrictive physiology persists. Echocardiography now shows severe tricuspid regurgitation. He has no cirrhosis, sepsis or life-limiting illness.[1]
- Pericardiectomy is recommended in permanent constriction if there is no active inflammation or anti-inflammatory treatment is not successful after 3–6 months (Class I, Level C).[1]
- Surgical pericardiectomy is also recommended for persistent constrictive pericarditis despite medical therapy to improve symptoms and survival (Class I, Level C).[1]
- It should be complete rather than partial anterior or anterophrenic, at a high-volume centre with the required expertise.[1]
- Tricuspid valve repair is recommended in pericardial constriction with severe tricuspid regurgitation to improve symptoms and survival (Class I, Level C).[1]
- CT before surgery evaluates the anatomy and extent of calcification.[1]
Step 4 — Outcome and follow-up
- ESC 2025 gives a historical operative mortality of 6%–10% for pericardiectomy, with better results for early surgery in high-volume centres and the lowest risk (<1.5%) with idiopathic causes.[1]
- In a 163-patient single-centre series, 7-year survival after pericardiectomy was 66% for post-surgical constriction, against 88% for idiopathic and 27% for post-radiation constriction.[20]
- Cases of constriction after pericardiectomy have been reported, especially after partial pericardiectomy.[1]
Examiner criteria
- Pass: recognises constriction from right heart failure with a near-normal natriuretic peptide; asks for multimodality imaging and applies the Mayo criteria; treats the inflamed constriction first; refers for complete pericardiectomy at an experienced centre when constriction persists without inflammation; repairs severe tricuspid regurgitation at the same operation.[1]
- Fail: sends a stable patient with active pericardial inflammation straight to pericardiectomy, excludes constriction on a normal natriuretic peptide, or delays surgery in persistent constriction.[1]
References3ShowHide
- [1]Schulz-Menger J, et al. 2025 ESC Guidelines for the management of myocarditis and pericarditis. Eur Heart J, 2025.PMID 40878297
- [20]Bertog SC, et al. Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol, 2004.PMID 15093882
- [22]Kwan TN, et al. Epidemiology and Risk Factors for Constrictive Pericarditis in a Statewide Australian Cohort of Patients With Pericardial Disease. Can J Cardiol, 2026.PMID 40983194